| IPO Listing At | BSE, NSE |
| IPO Issue Type | Book Build Issue |
| Issue Size | ₹2497.92 Cr |
| Offer for Sale | ₹2497.92 Cr |
| Face Value | โน1 Per Equity Share |
| Price Band | โน1265.00-1329.00 per share |
| Discount | Retail: 0.00,Employee: 0.00 |
| BSE Code | 544309 |
| NSE Code | IKS |
| Registrar | MUFG Intime India Pvt.Ltd. |
| Lead Managers | ICICI Securities Ltd. |
| Allotment Status | |
| DRHP | |
| RHP | |
| Final Prospectus | |
| Anchor List |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 11 shares and in multiples thereof
Incorporated in 2006, Inventurus Knowledge Solutions Limited (IKS Health) provides services to healthcare enterprises such as handling administrative chores/work. The company helps doctors and other healthcare providers by handling their paperwork and administrative tasks. IKS Health offers services such as clinical support, medical documentation management, virtual medical scribing and more.
The company is a healthcare technology company that helps make it easier and faster for patients to get the care they need while reducing the administrative burden on healthcare providers.
Inventurus Knowledge Solutions Limited offer a platform that enables healthcare enterprises in outpatient and inpatient care.
As of September 30, 2024, IKS serves over 778 healthcare organizations, including health systems, multi-specialty medical groups, and other outpatient and inpatient providers. Key clients include Mass General Brigham Inc., Texas Health Care PLLC, and The GI Alliance Management.
The company has a team of over 13,528 employees, including 2,612 clinically-trained professionals, and a consultative sales force operating in the US, Canada, and Australia.
Their Competitive Strengths:
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 2,790.52 | 3,027.52 | 988.31 | 787.52 |
| Total Income | 1,294.61 | 1,857.94 | 1,060.16 | 784.47 |
| Profit After Tax | 208.58 | 370.49 | 305.23 | 232.97 |
| NET Worth | 1,377.11 | 1,157.86 | 828.64 | 647.07 |
| Reserves and Surplus | 1,360.17 | 1,140.94 | 811.80 | 630.26 |
| Total Borrowing | 828.63 | 1,193.42 | ||
| Amount in ₹ Crore | ||||
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 32% |
| ROCE | 31.56% |
| Debt / Equity | -0.06% |
| RoNW | 32% |
| PAT Margin | 20.38% |
| Price to Book Value | 19.07 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (โน) | 21.59 | 24.31 |
| P/E (x) | 61.55 | 54.66 |
| Promoter Holding | 67.66% | 63.72% |
| Market Cap | โน22802.07 Cr. | |